Recent advances in the ARID family: focusing on roles in human cancer
暂无分享,去创建一个
Wei Song | Hong Zhao | Zhen Huang | Xinyu Bi | Wei Song | J. Cai | X. Bi | Hong Zhao | Zhen Huang | Jianguo Zhou | Jianguo Zhou | Chen Lin | Jianjun Zhao | Zhiyu Li | Jianqiang Cai | Jian-jun Zhao | Zhi-yu Li | Chen Lin | Jian‐jun Zhao
[1] A. Giuliano,et al. Recognition of an epitope of a breast cancer antigen by human antibody , 1999, Breast Cancer Research and Treatment.
[2] A. Veronese,et al. Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene , 2006, Genes, chromosomes & cancer.
[3] P. Dallas,et al. Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. , 2004, The Biochemical journal.
[4] M. Meyerson,et al. Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1 , 2011, Proceedings of the National Academy of Sciences.
[5] D. Leprince,et al. HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A. , 2009, Biochemical and biophysical research communications.
[6] Y F Lau,et al. Expression analysis of thirty one Y chromosome genes in human prostate cancer , 2000, Molecular carcinogenesis.
[7] Ben S. Wittner,et al. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.
[8] Franz Oswald,et al. Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex. , 2010, Genes & development.
[9] S. Ichwan,et al. E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53. , 2003, Molecular cancer research : MCR.
[10] M. Landthaler,et al. Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas , 2005, Modern Pathology.
[11] M. Loh,et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] R. Saint,et al. ARID proteins come in from the desert. , 2000, Trends in biochemical sciences.
[13] R. Young,et al. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. , 2005, Molecular cell.
[14] E. Li,et al. Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma. , 2013, Acta histochemica.
[15] D. Tyrrell,et al. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry†, ‡ , 2012, Hepatology.
[16] K. Pan,et al. Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer , 2012, PloS one.
[17] D. Hémon,et al. Are ARID5B and IKZF1 polymorphisms also associated with childhood acute myeloblastic leukemia: the ESCALE study (SFCE)? , 2013, Leukemia.
[18] Peer Bork,et al. SMART 7: recent updates to the protein domain annotation resource , 2011, Nucleic Acids Res..
[19] E. Stanbridge,et al. RBP1L1, a retinoblastoma-binding protein-related gene encoding an antigenic epitope abundantly expressed in human carcinomas and normal testis. , 2001, Journal of the National Cancer Institute.
[20] Tian-Li Wang,et al. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. , 2011, Cancer research.
[21] S. Nishikawa,et al. Epigenetic regulation of the neuroblastoma genes, Arid3b and Mycn , 2012, Oncogene.
[22] M. Toyoda,et al. Jumonji is a nuclear protein that participates in the negative regulation of cell growth. , 2000, Biochemical and biophysical research communications.
[23] Y. Shinkai,et al. A Jumonji (Jarid2) Protein Complex Represses cyclin D1 Expression by Methylation of Histone H3-K9* , 2009, Journal of Biological Chemistry.
[24] Xiaomei Wang,et al. Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell‐cycle control , 2007, The EMBO journal.
[25] Y. Tsunematsu,et al. E2FBP1/hDril1 modulates cell growth through downregulation of promyelocytic leukemia bodies , 2004, Cell Death and Differentiation.
[26] T. Pawlik,et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas , 2013, Nature Genetics.
[27] Dinshaw J. Patel,et al. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger , 2009, Nature.
[28] M. Relling,et al. ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence , 2010, Leukemia.
[29] B. Ponder,et al. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway , 2010, Molecular Cancer.
[30] Karen D. Cowden Dahl,et al. The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. , 2009, Neoplasia.
[31] L. Robison,et al. ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. , 2013, Leukemia research.
[32] Alan J. Tackett,et al. Identification of Small Molecule Inhibitors of Jumonji AT-rich Interactive Domain 1B (JARID1B) Histone Demethylase by a Sensitive High Throughput Screen* , 2013, The Journal of Biological Chemistry.
[33] D. Reinberg,et al. RBP1 Recruits the mSIN3-Histone Deacetylase Complex to the Pocket of Retinoblastoma Tumor Suppressor Family Proteins Found in Limited Discrete Regions of the Nucleus at Growth Arrest , 2001, Molecular and Cellular Biology.
[34] J. Taylor‐Papadimitriou,et al. Functional Analysis of the Transcription Supplemental Material , 2007 .
[35] J. Workman,et al. Breast Cancer Metastasis Suppressor 1 (BRMS1) Forms Complexes with Retinoblastoma-binding Protein 1 (RBP1) and the mSin3 Histone Deacetylase Complex and Represses Transcription* , 2004, Journal of Biological Chemistry.
[36] Michael Landthaler,et al. RBP2‐H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells , 2007, International journal of cancer.
[37] C. Chen,et al. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer , 2007, Proceedings of the National Academy of Sciences.
[38] S. Perrett,et al. Structural Insight into Recognition of Methylated Histone Tails by Retinoblastoma-binding Protein 1* , 2012, The Journal of Biological Chemistry.
[39] M. Landthaler,et al. Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells. , 2006, The Journal of investigative dermatology.
[40] B. Garcia,et al. H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence , 2012, Proceedings of the National Academy of Sciences.
[41] R. Bernards,et al. The Histone Demethylase Jarid1b (Kdm5b) Is a Novel Component of the Rb Pathway and Associates with E2f-Target Genes in MEFs during Senescence , 2011, PloS one.
[42] P. Dallas,et al. ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[43] A. E. Erson-Bensan,et al. miR-125b targets ARID3B in breast cancer cells. , 2012, Cell structure and function.
[44] K. Kalland,et al. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas , 2013, Modern Pathology.
[45] Danny R. Welch,et al. Allelic Variation and Differential Expression of the mSIN3A Histone Deacetylase Complex Gene Arid4b Promote Mammary Tumor Growth and Metastasis , 2012, PLoS genetics.
[46] E. Moran,et al. Nomenclature of the ARID family of DNA-binding proteins. , 2005, Genomics.
[47] S. Meier-Ewert,et al. A Novel Gene (PLU-1) Containing Highly Conserved Putative DNA/Chromatin Binding Motifs Is Specifically Up-regulated in Breast Cancer* , 1999, The Journal of Biological Chemistry.
[48] I. Shih,et al. Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma , 2012, International Journal of Gynecologic Cancer.
[49] A. Agulnik,et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. , 1995, Science.
[50] C. Croce,et al. Bdp, a new member of a family of DNA-binding proteins, associates with the retinoblastoma gene product. , 1999, Cancer research.
[51] M. Zhou,et al. The von Hippel–Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C , 2012, Oncogene.
[52] H. Kiyonari,et al. Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo , 2013, Proceedings of the National Academy of Sciences.
[53] C. Liu,et al. Chromatin remodeling: recruitment of histone demethylase RBP2 by Madl for transcriptional repression of a Myc target gene, telomerase reverse transcriptase , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[54] Giovanni Parmigiani,et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma , 2012, Nature Genetics.
[55] Arthur L. Beaudet,et al. Identification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor Genes , 2008, Journal of the National Cancer Institute.
[56] K. Itakura,et al. Repression by a differentiation-specific factor of the human cytomegalovirus enhancer. , 1996, Nucleic acids research.
[57] J. Qin,et al. Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44+ Cells and Evidence for Epigenetic Mechanisms , 2011, PloS one.
[58] Yi-Chun Chen,et al. The JmjN Domain of Jhd2 Is Important for Its Protein Stability, and the Plant Homeodomain (PHD) Finger Mediates Its Chromatin Association Independent of H3K4 Methylation*♦ , 2010, The Journal of Biological Chemistry.
[59] Wayne Tam,et al. Reticuloendotheliosis Virus Strain T Induces miR-155, Which Targets JARID2 and Promotes Cell Survival , 2009, Journal of Virology.
[60] T. Pandita,et al. E2FBP1 antagonizes the p16INK4A-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability , 2011, International Journal of Oral Science.
[61] Arnaud Pigneux,et al. Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study , 2012, British journal of haematology.
[62] C. Webb,et al. Loss of Bright/ARID3a Function Promotes Developmental Plasticity , 2010, Stem cells.
[63] Keith A. Boroevich,et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators , 2012, Nature Genetics.
[64] Kairong Cui,et al. PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. , 2005, Genes & development.
[65] Michael A Choti,et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma , 2011, Nature Genetics.
[66] Zhengyan Kan,et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer , 2011, Nature Genetics.
[67] R. Stevenson,et al. Mutations in JARID1C are associated with X-linked mental retardation, short stature and hyperreflexia , 2008, Journal of Medical Genetics.
[68] K. Helin,et al. RBP2 Belongs to a Family of Demethylases, Specific for Tri-and Dimethylated Lysine 4 on Histone 3 , 2007, Cell.
[69] C. Schmidt,et al. Characterization of a new ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated immunoglobulin gene transcription. , 2011, Molecular immunology.
[70] Qin Lu,et al. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population. , 2013, Gene.
[71] Amanda J. Guise,et al. The functional interactome landscape of the human histone deacetylase family , 2013, Molecular systems biology.
[72] C. Webb,et al. Expression of bright at two distinct stages of B lymphocyte development. , 1998, Journal of immunology.
[73] H. Katagiri,et al. Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma , 2012, Modern Pathology.
[74] Ryuji Kobayashi,et al. The Human SWI-SNF Complex Protein p270 Is an ARID Family Member with Non-Sequence-Specific DNA Binding Activity , 2000, Molecular and Cellular Biology.
[75] Gurpreet W. Tang,et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.
[76] M. Torbenson,et al. ARID2: A new tumor suppressor gene in hepatocellular carcinoma , 2011, Oncotarget.
[77] Huajian Gao,et al. Characterization of BRCAA1 and its novel antigen epitope identification. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[78] P. Brousset,et al. B-cell regulator of immunoglobulin heavy-chain transcription (Bright)/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells , 2012, Leukemia.
[79] S. Ishikawa,et al. ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein–Barr virus infection and microsatellite instability , 2012, Virchows Archiv.
[80] Hans Clevers,et al. Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. , 2002, The Biochemical journal.
[81] C. Badenas,et al. A novel mutation in JARID1C gene associated with mental retardation , 2006, European Journal of Human Genetics.
[82] A. Noske,et al. Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? , 2012, Modern Pathology.
[83] E. Moran,et al. DNA-binding properties of ARID family proteins , 2005, Nucleic acids research.
[84] Maite Huarte,et al. The X-Linked Mental Retardation Gene SMCX/JARID1C Defines a Family of Histone H3 Lysine 4 Demethylases , 2007, Cell.
[85] Lincoln D. Stein,et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.
[86] Karen D. Cowden Dahl,et al. ARID3B Induces Tumor Necrosis Factor Alpha Mediated Apoptosis While a Novel ARID3B Splice Form Does Not Induce Cell Death , 2012, PloS one.
[87] Anjanabha Saha,et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression , 2006, Nature.
[88] H. Ishii,et al. Depletion of JARID1B induces cellular senescence in human colorectal cancer. , 2013, International journal of oncology.
[89] B. Spencer‐Dene,et al. PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells. , 2011, International journal of oncology.
[90] S Gowrishankar,et al. ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines , 2013, British Journal of Cancer.
[91] P. Dallas,et al. Expression of p270 (ARID1A), a component of human SWI/SNF complexes, in human tumors , 2004, International journal of cancer.
[92] R. Clubb,et al. Solution structure of the DNA binding domain from Dead ringer, a sequence‐specific AT‐rich interaction domain (ARID) , 1999, The EMBO journal.
[93] W. Lestari,et al. Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage. , 2012, Biochemical and biophysical research communications.
[94] J. Gécz,et al. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. , 2005, American journal of human genetics.
[95] T. Takeuchi,et al. Roles of jumonji and jumonji family genes in chromatin regulation and development , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.
[96] H. Katagiri,et al. Frequent Loss of Tumor Suppressor ARID1A Protein Expression in Adenocarcinomas/Adenosquamous Carcinomas of the Uterine Cervix , 2011, International Journal of Gynecologic Cancer.
[97] S. Imbeaud,et al. Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma , 2013, International journal of cancer.
[98] Yi Zhang,et al. New Nomenclature for Chromatin-Modifying Enzymes , 2007, Cell.
[99] Bin Tean Teh,et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes , 2012, Nature Genetics.
[100] Meng Li,et al. Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types , 2011, Human mutation.
[101] Ming Jiang,et al. ARID4A and ARID4B regulate male fertility, a functional link to the AR and RB pathways , 2013, Proceedings of the National Academy of Sciences.
[102] B. Gui,et al. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14. , 2011, Cancer research.
[103] P. Tonin,et al. An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer , 2012, Oncogene.
[104] Dongkyoon Kim,et al. A Regulated Nucleocytoplasmic Shuttle Contributes to Bright's Function as a Transcriptional Activator of Immunoglobulin Genes , 2006, Molecular and Cellular Biology.
[105] R. Janknecht,et al. Repression of Smad3 activity by histone demethylase SMCX/JARID1C. , 2008, Biochemical and biophysical research communications.
[106] P. Dallas,et al. The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest. , 2005, Cancer research.
[107] Tian-Li Wang,et al. Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma , 2010, Science.
[108] Alexander Roesch,et al. A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth , 2010, Cell.
[109] M. Cazzola,et al. Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies , 2012, American journal of hematology.
[110] G. Daley,et al. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence , 2002, Nature Cell Biology.
[111] Paul Tempst,et al. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. , 2007, Molecular cell.
[112] Richard A. Moore,et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. , 2010, The New England journal of medicine.
[113] I. Shih,et al. Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions. , 2012, Neoplasia.